Reduced infancy and childhood epilepsy following hypothermia-treated neonatal encephalopathy

Xun Liu1, Sally Jary1, Frances Cowan1

  • 1Neonatal Neuroscience, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Epilepsia
|September 30, 2017
PubMed

Insights

Neonatal encephalopathy treated with cooling therapy can lead to epilepsy in children. This study found 13% of children developed epilepsy by early school age, with 7% requiring medication.

Area of Science:

  • Neonatal neurology
  • Pediatric epilepsy
  • Therapeutic hypothermia

Background:

  • Neonatal encephalopathy (NE) is a serious condition in newborns.
  • Therapeutic hypothermia (cooling) is a standard treatment for NE following perinatal asphyxia.
  • Epilepsy is a common long-term complication of NE.

Purpose of the Study:

  • To determine the proportion of infants treated with therapeutic hypothermia for NE who develop epilepsy.
  • To assess epilepsy rates and antiepileptic drug (AED) use up to 8 years of age.
  • To identify predictors of epilepsy in this cohort.

Main Methods:

  • A regional cohort of 151 infants with NE underwent 72-hour cooling.
  • Clinical and amplitude-integrated electroencephalography (aEEG) monitored seizures.
  • Brain MRI, neurodevelopmental outcomes, and epilepsy diagnoses (ILAE criteria) were assessed up to 8 years.
  • Predictors of epilepsy, including aEEG severity and MRI scores, were analyzed.

Main Results:

  • Seizures occurred in 57% before cooling and 48% during/after cooling.
  • At 2 years, 6% had epilepsy (2% on AEDs); by 4-8 years, 13% had epilepsy (7% on AEDs).
  • Higher MRI scores and more AEDs for neonatal seizures predicted childhood epilepsy.
  • Children with epilepsy had significantly poorer neurodevelopmental outcomes and higher rates of cerebral palsy.

Conclusions:

  • Epilepsy develops in a significant proportion of infants treated for NE with cooling, persisting into early school age.
  • AED requirements in this cohort were lower than in previous cooling trials.
  • Neonatal seizure characteristics, aEEG severity, and MRI findings are important predictors of long-term epilepsy risk.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276